Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial
E Nisbet-Brown, NF Olivieri, PJ Giardina, RW Grady… - The Lancet, 2003 - thelancet.com
Background Transfusional iron overload is a potentially fatal complication of the treatment of
thalassaemia. We aimed to investigate short-term efficacy, pharmacokinetic/pharma …
thalassaemia. We aimed to investigate short-term efficacy, pharmacokinetic/pharma …
Academic freedom in clinical research.
DG Nathan, DJ Weatherall - Science and Society: An Anthology …, 2014 - books.google.com
“I s that the appeared university–industrial under this eye-catching complex out of control?”
The editorial title in Nature in January 2001 came to the conclusion that links between …
The editorial title in Nature in January 2001 came to the conclusion that links between …
[BOOK][B] The drug trial: Nancy Olivieri and the scandal that rocked the Hospital for Sick Children
M Shuchman - 2005 - books.google.com
Winner of the Writers' Trust of Canada's Shaughnessy Cohen Prize for Political Writing and
the Canadian Science Writers' Association's Science in Society Book Award. Poison-pen …
the Canadian Science Writers' Association's Science in Society Book Award. Poison-pen …
Better governance in academic health sciences centres: moving beyond the Olivieri/Apotex Affair in Toronto
LE Ferris, PA Singer, CD Naylor - Journal of medical ethics, 2004 - jme.bmj.com
The Toronto experience suggests that there may be several general lessons for academic
health sciences complexes to learn from the Olivieri/Apotex affair (OAA) regarding the ethics …
health sciences complexes to learn from the Olivieri/Apotex affair (OAA) regarding the ethics …
[HTML][HTML] Freedom of Science–Can Industry Influence What Scientists Publish?
R Ziegler, O Schnell, B Kulzer, J Gilbart… - European …, 2014 - ncbi.nlm.nih.gov
The right of scientists to publish data from their preclinical and clinical studies is a much-
cherished principle and is vital to the freedom of science. Indeed, full and candid reporting of …
cherished principle and is vital to the freedom of science. Indeed, full and candid reporting of …
Clinical research: a tale of two studies.
DG Nathan - Transactions of the American Clinical and …, 2003 - ncbi.nlm.nih.gov
Threats to the status of clinical research have been well documented in the past three
decades, and the National Institutes of Health and the Congress have done much to …
decades, and the National Institutes of Health and the Congress have done much to …
[PDF][PDF] Academic freedom, scientific integrity, and conflicts of interest: Lessons learned from the University of Toronto
N Olivieri - Hypothesis, 2005 - Citeseer
To steal a memorable line up front:“Accounts of the Olivieri-Apotex-Sick Kids Hospital-
University of Toronto controversy have multiplied and divided to the point where they would …
University of Toronto controversy have multiplied and divided to the point where they would …
I beg to differ
D Naylor - CMAJ, 2002 - Can Med Assoc
C. David Naylor, Dean of Medicine at the University of Toronto, declares that the university
and the Hospital for Sick Children (HSC) have “moved on” from the scandal surrounding the …
and the Hospital for Sick Children (HSC) have “moved on” from the scandal surrounding the …
Independent inquiry
P Baird, J Thompson, J Downie - CMAJ, 2002 - Can Med Assoc
Although we applaud the coverage1-3 given in the Feb. 19, 2002, issue of the case of Nancy
Olivieri, Apotex, the Hospital for Sick Children and the University of Toronto, the editorial …
Olivieri, Apotex, the Hospital for Sick Children and the University of Toronto, the editorial …
[HTML][HTML] I beg to differ
N Olivieri - CMAJ, 2002 - Can Med Assoc
C. David Naylor, Dean of Medicine at the University of Toronto, declares that the university
and the Hospital for Sick Children (HSC) have “moved on” from the scandal surrounding the …
and the Hospital for Sick Children (HSC) have “moved on” from the scandal surrounding the …
